Follow the ALK-Abelló A/S share price and the full directors' dealings record of the company, a listed equity based in Denmark. Shares are quoted on DK DK, under the authority of Finanstilsynet DK. Operating in the Health Care sector, ALK-Abelló A/S has logged 0 insider filings. Market capitalisation: €53.2bn. Every trade is accessible without an account.
Analysts rate ALK-Abelló A/S Strong Buy (bullish), based on 4 analysts. Average price target: DKK 298.75.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
0 of 0 declarations
ALK-Abelló A/S is a Danish company focused on developing treatments for allergies. It specializes in allergen immunotherapy and offers solutions for patients suffering from respiratory and food allergies.